<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Tinospora crispa,</italic> which had the top CI value in this study, is also used for treatments of infectious diseases in other parts of the world, and its extracts have a broad range of pharmacological activities [
 <xref rid="B37-antibiotics-09-00298" ref-type="bibr">37</xref>]. For antimicrobial activities, 
 <italic>T. crispa</italic> includes effects on 
 <italic>Staphylococcus aureus, Streptococcus pneumonia, Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans,</italic> and 
 <italic>Saccharomyces cerevisiae</italic> [
 <xref rid="B38-antibiotics-09-00298" ref-type="bibr">38</xref>,
 <xref rid="B39-antibiotics-09-00298" ref-type="bibr">39</xref>]. The plant produces a variety of secondary metabolites including lactones, steroids, flavonoids, lignan and alkaloids. The compound names and structures are shown in [
 <xref rid="B37-antibiotics-09-00298" ref-type="bibr">37</xref>]. Specifically, 
 <italic>T. crispa</italic> produces furanoditerpenes, which are characteristic of the species [
 <xref rid="B37-antibiotics-09-00298" ref-type="bibr">37</xref>]. 
 <italic>Cleidion javanicum</italic> and 
 <italic>Litsea cubeba</italic> also have the potential for antimicrobial activities. 
 <italic>Cleidion javanicum</italic> produces various essential oils that have antimicrobial activities. The major compounds are ethyl linoleolate, hexadecanoic acid, and trans-phytol [
 <xref rid="B40-antibiotics-09-00298" ref-type="bibr">40</xref>]. Essential oils from 
 <italic>L. cubeba</italic>, citral and limonene, have antibacterial and antifungal activities [
 <xref rid="B41-antibiotics-09-00298" ref-type="bibr">41</xref>].
</p>
